Related Experiment Videos
Life-threatening tamoxifen-induced hypercalcaemia.
P M Mulvenna1, A J Wright, T J Podd
1Northern Centre for Cancer Treatment, Newcastle General Hospital, Newcastle upon Tyne, UK.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|August 28, 1999
Summary
Tamoxifen-induced flare in metastatic breast cancer can be fatal if not promptly treated. However, patients with skeletal metastases and hypercalcemia from this flare may have a durable prognosis.
Area of Science:
- Oncology
- Endocrinology
Background:
- Metastatic breast carcinoma presents unique clinical challenges.
- Tamoxifen is a common endocrine therapy for breast cancer.
Observation:
- This case report highlights tamoxifen-induced tumor flare.
- Tumor flare can manifest with hypercalcemia.
Findings:
- Tamoxifen-induced flare, though rare, can be fatal and requires prompt recognition and management.
- Hypercalcemia in tamoxifen-induced flare indicates metastatic disease, often skeletal.
Implications:
- Early identification and management of tamoxifen-induced flare are crucial for patient survival.
- Skeletal confinement of metastases in this context may predict a favorable long-term prognosis.